E-LIB Suche - Ergebnisse für: Hochhauser, D.

1

PB2099: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-1607, A FIRST-..:

Sharp, A. ; Williams, A. ; Blagden, S....
HemaSphere. 6 (2022) - p. 1970-1971 , 2022

Link: https://doi.org/10.1097/..

2

Health-related quality of life in patients with a germline ..:

Hammel, P. ; Kindler, H.L. ; Reni, M....
Annals of Oncology. 30 (2019) 12 - p. 1959-1968 , 2019

Link: https://doi.org/10.1093/..

3

Time to endoscopic intervention in patients with upper gast..:

Singer, R ; Campbell, P ; Fernandes, C...
BMC Cancer. 17 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

4

P971: Neurological outcomes following chemotherapy treatmen..:

Park, S. ; Davare, M. ; Bridgewater, J....
Clinical Neurophysiology. 125 (2014) - p. S306 , 2014

Link: https://doi.org/10.1016/..

5

P14 Retrospective series of 22 cases with small bowel adeno..:

Sagmeister, M. ; Bridgewater, J. ; Hochhauser, D.
European Journal of Cancer. 50 (2014) - p. S13 , 2014

Link: https://doi.org/10.1016/..

6

445 MEK inhibition enhances gemcitabine efficacy by increas..:

Vena, F. ; Li Causi, E. ; Hagemann, T....
European Journal of Cancer. 50 (2014) - p. 146 , 2014

Link: https://doi.org/10.1016/..

7

Streamlining the Head and Neck Treatment Process in Radiati..:

Kapur, A. ; Riebling, N. ; Galli, B....
International Journal of Radiation Oncology*Biology*Physics. 84 (2012) 3 - p. S151 , 2012

Link: https://doi.org/10.1016/..

8

521 EGFR nuclear translocation modulates DNA repair followi..:

Liccardi, G. ; Hartley, J.A. ; Hochhauser, D.
European Journal of Cancer Supplements. 8 (2010) 7 - p. 166 , 2010

Link: https://doi.org/10.1016/..

9

526 A potent PBD-heterocyclic polyamide conjugate targeting..:

Brucoli, F. ; Hawkins, R.M. ; Wells, G....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 168 , 2010

Link: https://doi.org/10.1016/..

10

Primary tumour resection and survival in the palliative man..:

Bajwa, A. ; Blunt, N. ; Vyas, S....
European Journal of Surgical Oncology (EJSO). 35 (2009) 2 - p. 164-167 , 2009

Link: https://doi.org/10.1016/..

11

A Comparison of Hickman Line- and Port-a-Cath-associated Co..:

Ng, F. ; Mastoroudes, H. ; Paul, E....
Clinical Oncology. 19 (2007) 7 - p. 551-556 , 2007

Link: https://doi.org/10.1016/..

12

Epidermal Growth Factor Receptor Expression and Activation ..:

Shah, T. ; Hochhauser, D. ; Frow, R....
Journal of Neuroendocrinology. 18 (2006) 5 - p. 355-360 , 2006

Link: https://doi.org/10.1111/..

13

497 POSTER Modulation of the repair of cisplatin-induced DN..:

Boone, J.J.M. ; Hochhauser, D. ; Hartley, J.A.
European Journal of Cancer Supplements. 4 (2006) 12 - p. 151 , 2006

Link: https://doi.org/10.1016/..

14

Upper GI and Oncology 02:

Spalding, D.R.C. ; Hochhauser, D. ; Hartley, J..
British Journal of Surgery. 89 (2002) S1 - p. 50-50 , 2002

Link: https://doi.org/10.1046/..

15

33. Early results of radiolabelled lanreotide in disseminat..:

Buscombe, J. R. ; Caplin, M. E. ; Chao, D....
Nuclear Medicine Communications. 22 (2001) 4 - p. 445 , 2001

Link: https://doi.org/10.1097/..